Isoform-Specific Toxicity of Mecp2 in Postmitotic Neurons: Suppression of Neurotoxicity by FoxG1
Authors:
- Farah H. BardaiFBFarah H. Bardai
- Chi MaCMChi Ma
- Valerie PriceVPValerie Price
- Varun RawatVRVarun Rawat
- Pragya VermaPVPragya Verma
- Vinodh NarayananVNVinodh Narayanan
- Santosh R. D'MElloSDSantosh R. D'MEllo
Open Access
- 22 February 2012
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 32 (8) , 2846-2855
Abstract
The methyl-CpG binding protein 2 (MeCP2) is a widely expressed protein, the mutations of which cause Rett syndrome. The level of MeCP2 is highest in the brain where it is expressed selectively in mature neurons. Its functions in postmitotic neurons are not known. TheMeCP2gene is alternatively spliced to generate two proteins with different N termini, designated asMeCP2-e1andMeCP2-e2. The physiological significance of these two isoforms has not been elucidated, and it is generally assumed they are functionally equivalent. We report that in cultured cerebellar granule neurons induced to die by low potassium treatment and in Aβ-treated cortical neurons,Mecp2-e2expression is upregulated whereas expression of theMecp2-e1isoform is downregulated. Knockdown ofMecp2-e2protects neurons from death, whereas knockdown of the e1 isoform has no effect. Forced expression of MeCP2-e2, but not MeCP2-e1, promotes apoptosis in otherwise healthy neurons. We find that MeCP2-e2 interacts with the forkhead protein FoxG1, mutations of which also cause Rett syndrome. FoxG1 has been shown to promote neuronal survival and its downregulation leads to neuronal death. We find that elevated FoxG1 expression inhibits MeCP2-e2 neurotoxicity. MeCP2-e2 neurotoxicity is also inhibited by IGF-1, which prevents the neuronal death-associated downregulation of FoxG1 expression, and by Akt, the activation of which is necessary for FoxG1-mediated neuroprotection. Finally, MeCP2-e2 neurotoxicity is enhanced if FoxG1 expression is suppressed or in neurons cultured fromFoxG1-haplodeficient mice. Our results indicate that Mecp2-e2 promotes neuronal death and that this activity is normally inhibited by FoxG1. Reduced FoxG1expression frees MecP2-e2 to promote neuronal death.Keywords
This publication has 45 references indexed in Scilit:
- Neuroprotection by Histone Deacetylase-7 (HDAC7) Occurs by Inhibition of c-jun Expression through a Deacetylase-independent MechanismJournal of Biological Chemistry, 2011
- The Role of MeCP2 in Brain Development and Neurodevelopmental DisordersCurrent Psychiatry Reports, 2010
- Atypical Rett syndrome with selective FOXG1 deletion detected by comparative genomic hybridization: case report and review of literatureEuropean Journal of Human Genetics, 2009
- Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant miceProceedings of the National Academy of Sciences, 2009
- A chemical compound commonly used to inhibit PKR, {8‐(imidazol‐4‐ylmethylene)‐6H‐azolidino[5,4‐g] benzothiazol‐7‐one}, protects neurons by inhibiting cyclin‐dependent kinaseEuropean Journal of Neuroscience, 2008
- FOXG1 Is Responsible for the Congenital Variant of Rett SyndromeThe American Journal of Human Genetics, 2008
- MeCP2, a Key Contributor to Neurological Disease, Activates and Represses TranscriptionScience, 2008
- Foxg1 Haploinsufficiency Reduces the Population of Cortical Intermediate Progenitor Cells: Effect of Increased p21 ExpressionCerebral Cortex, 2007
- Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genesProceedings of the National Academy of Sciences, 2007
- Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxiaNeuroscience, 2007